| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |